Cladribine(BioNxt Solutions)

N/A

Report date: 2024/12/17 15:47:36

Base Information

Drug NameCladribine(BioNxt Solutions)
Drug Alias NameBNT24002BNT-24002BNT23001BNT-23001BNT23002 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibonucleotide reductase inhibitorsImmunosuppressants
TargetsRibonucleotide reductase
Therapy Area/IndicationsLupus NephritisMultiple SclerosisMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioNxt Solutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioNxt Solutions Inc
Inactive CompaniesN/A
Active IndicationsLupus NephritisMultiple SclerosisMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A